Diagnosis of Undifferentiated Carcinoma with the Help of Monoclonal Antibodies

Main Article Content

Abid Jameel
Tariq Iqbal
Jehanzeb Khan
Muhammad Ali Khan

Abstract

Undifferentiated carcinomas and malignancy of unknown orgin (MUO) present one of the  greatest challenges to the pathologist as well as oncologist. Without knowing the primary or the type of primary tumour, it becomes very difficult for the oncologist to plan treatment for the  patients. Despite exhaustive investigations, 5% of all cancer patients (and 70% of MUOs) and still have an unidentified primary tumour. due to this high rate of failure to identify the primary or the type of primary tumour, coupled with the fact that prognosis is very poor in these patients, one should only try to eliminate the most treatable tujmours (e.g. breast, ovarian, Testicular Carcinoma).

Article Details

How to Cite
1.
Jameel A, Iqbal T, Khan J, Khan MA. Diagnosis of Undifferentiated Carcinoma with the Help of Monoclonal Antibodies. J Postgrad Med Inst [Internet]. 2011 Aug. 29 [cited 2022 Dec. 7];10(1). Available from: https://jpmi.org.pk/index.php/jpmi/article/view/532
Section
Case Report

Most read articles by the same author(s)

1 2 3 > >>